Literature DB >> 27256636

Parkinson disease: Dopamine receptor variants improve response to rasagiline in PD.

Ian Fyfe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27256636     DOI: 10.1038/nrneurol.2016.83

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study.

Authors:  Mario Masellis; Shannon Collinson; Natalie Freeman; Maria Tampakeras; Joseph Levy; Amir Tchelet; Eli Eyal; Elijahu Berkovich; Rom E Eliaz; Victor Abler; Iris Grossman; Cheryl Fitzer-Attas; Arun Tiwari; Michael R Hayden; James L Kennedy; Anthony E Lang; Jo Knight
Journal:  Brain       Date:  2016-05-13       Impact factor: 13.501

  1 in total
  1 in total

1.  Rasagiline Sensitive Dopamine D2 Receptor Gene Variants: A Step Forward Toward More Personalized Antiparkinsonian Therapy.

Authors:  Shakya Bhattacharjee; Emily Hughes; Kher Lik Ng
Journal:  Mov Disord Clin Pract       Date:  2016-10-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.